Recombinant
RabMAb

Anti-CD3 zeta antibody [EP286Y] (ab40804)

Publishing research using ab40804? Please let us know so that we can cite the reference in this datasheet.

ab40804 has been referenced in 2 publications.

  • Schneider D  et al. A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines. J Immunother Cancer 5:42 (2017). PubMed: 28515942
  • Zhang Q  et al. Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma. J Immunol Res 2017:6915912 (2017). PubMed: 29423418

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up